Abstract
Topical bimatoprost was FDA approved in December of 2008 for the treatment of eyelash hypotrichosis. Since its approval, some physicians have advocated the use of bimatoprost "off label" for hair growth in other areas, such as the scalp or eyebrows, but there has yet to be published scientific evidence to support this use. We report one of the first cases of significant eyebrow hair growth in a patient after use of topical bimatoprost for eyebrow hypotrichosis.
| Original language | English |
|---|---|
| Pages (from-to) | 106-108 |
| Number of pages | 3 |
| Journal | Journal of Drugs in Dermatology |
| Volume | 11 |
| Issue number | 1 |
| State | Published - Jan 2012 |